Profile picture

Doctor Mariam Anjum

Baerum Hospital, Baerum (Norway)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Timing of stroke risk reassessment in atrial fibrillation patients with CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study
Presentation
Timing of stroke risk reassessment in atrial fibrillation patients with CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study
Atrial fibrillation patients at intermediate risk of stroke rapidly progress to high stroke risk: A nationwide registry study (AFNOR).
Presentation
Atrial fibrillation patients at intermediate risk of stroke rapidly progress to high stroke risk: A nationwide registry study (AFNOR).
Stroke rates in non-anticoagulated individuals with and without atrial fibrillation and one non-sex CHA2DS2-VASc risk factor: a nationwide registry-based cohort (Atrial Fibrillation in Norway - AFNOR)
Presentation
Stroke rates in non-anticoagulated individuals with and without atrial fibrillation and one non-sex CHA2DS2-VASc risk factor: a nationwide registry-based cohort (Atrial Fibrillation in Norway - AFNOR)
Oral anticoagulation in atrial fibrillation patients at intermediate risk of stroke: a nationwide registry-based cohort (Atrial Fibrillation in Norway - AFNOR)
Presentation
Oral anticoagulation in atrial fibrillation patients at intermediate risk of stroke: a nationwide registry-based cohort (Atrial Fibrillation in Norway - AFNOR)
Time trends in incidence rates of atrial fibrillation-related strokes in Norway 2001-2014: a nationwide analysis using data from the cardiovascular disease in norway (CVDNOR) project.
Presentation
Time trends in incidence rates of atrial fibrillation-related strokes in Norway 2001-2014: a nationwide analysis using data from the cardiovascular disease in norway (CVDNOR) project.

ESC 365 is supported by